Ceftazidime
- Generic Name
- Ceftazidime
- Brand Names
- Avycaz, Fortaz, Tazicef, Zavicefta
- Drug Type
- Small Molecule
- Chemical Formula
- C22H22N6O7S2
- CAS Number
- 72558-82-8
- Unique Ingredient Identifier
- DZR1ENT301
- Background
Bacteria possess a cell wall comprising a glycopeptide polymer commonly known as peptidoglycan, which is synthesized and remodelled through the action of a family of enzymes known as "penicillin-binding proteins" (PBPs). β-lactam antibiotics, including cephalosporins, are PBP inhibitors that, through inhibition of essential PBPs, result in impaired cell wall...
- Indication
Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria...
- Associated Conditions
- Bacteremia, Bacterial Infections, Bacterial Septicemia, Bone and Joint Infections, Bronchopulmonary Infection, Central Nervous System Infections, Complicated Intra-Abdominal Infections (cIAIs), Complicated Skin and Soft Tissue Infection, Complicated Urinary Tract Infection, Complicated Urinary Tract Infections caused by susceptible Gram-negative microorganisms, Fever caused by susceptible bacteria, Gynecological Infection, Intraabdominal Infections, Lower Respiratory Tract Infection (LRTI), Meningitis, Bacterial, Nosocomial Pneumonia, Peritoneal Dialysis Associated Peritonitis, Skin and skin structure infections, Urinary Tract Infection, Ventilator-associated Bacterial Pneumonia caused by susceptible Gram-negative microorganisms, Chronic suppurative Otitis media, Hospital-acquired bacterial pneumonia caused by susceptible Gram-negative microorganisms, Malignant Otitis Externa, Susceptible Intra-Abdominal Infection caused by susceptible Gram-negative microorganism
- Associated Therapies
- -
Adverse Drug Reactions of Different Brands of Ceftazidime Injection
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2005-09-15
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 536
- Registration Number
- NCT00173901
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.